Nomura Micro Science (6254) Q1 2025 earnings summary

Executive summary

• Orders increased 15.3% year-over-year to ¥7,589 million, but net sales fell 40.2% to ¥7,629 million due to the completion of large-scale projects in the prior year.

• Operating profit dropped 78.2% year-over-year to ¥362 million, and profit attributable to owners of parent declined 63.2% to ¥411 million.

• The company is executing its medium-term plan focused on profitability, capital efficiency, and sustainability, with a strong emphasis on the semiconductor and pharmaceutical sectors.

Financial highlights

• Net sales: ¥7,629 million (down 40.2% year-over-year).

• Operating profit: ¥362 million (down 78.2% year-over-year).

• Ordinary profit: ¥494 million (down 76.4% year-over-year).

• Profit attributable to owners of parent: ¥411 million (down 63.2% year-over-year).

• Basic EPS: ¥10.95 (down from ¥30.01 year-over-year, adjusted for share split).

Outlook and guidance

• Full-year forecast for FY2025 maintained: net sales ¥88,000 million (+20.5% year-over-year), operating profit ¥12,000 million (+12.7%), profit attributable to owners of parent ¥8,650 million (+8.4%).

• No change to previously announced earnings or dividend forecasts.